GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zenotech Laboratories Ltd (BOM:532039) » Definitions » Median PS Value

Zenotech Laboratories (BOM:532039) Median PS Value : ₹86.01 (As of Jun. 21, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Zenotech Laboratories Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Zenotech Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹6.03. Zenotech Laboratories's 10-Year median PS Ratio is 14.2637. Therefore, the Median PS Value for today is ₹86.01.

As of today (2024-06-21), Zenotech Laboratories's share price is ₹61.38. Zenotech Laboratories's Median PS Value is ₹86.01. Therefore, Zenotech Laboratories's Price to Median PS Value for today is 0.71.

The historical rank and industry rank for Zenotech Laboratories's Median PS Value or its related term are showing as below:

BOM:532039' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.35   Med: 0.52   Max: 0.72
Current: 0.71

During the past 13 years, the highest Price to Median PS Value of Zenotech Laboratories was 0.72. The lowest was 0.35. And the median was 0.52.

BOM:532039's Price-to-Median-PS-Value is ranked better than
58.61% of 505 companies
in the Drug Manufacturers industry
Industry Median: 0.79 vs BOM:532039: 0.71

Zenotech Laboratories Median PS Value Historical Data

The historical data trend for Zenotech Laboratories's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenotech Laboratories Median PS Value Chart

Zenotech Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 132.88 86.01

Zenotech Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 132.88 116.31 120.06 105.11 86.01

Competitive Comparison of Zenotech Laboratories's Median PS Value

For the Drug Manufacturers - Specialty & Generic subindustry, Zenotech Laboratories's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zenotech Laboratories's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zenotech Laboratories's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Zenotech Laboratories's Price-to-Median-PS-Value falls into.



Zenotech Laboratories Median PS Value Calculation

Zenotech Laboratories's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=6.03*14.2637
=86.01

10-Year Median PS Ratio is 14.2637.
Zenotech Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹6.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zenotech Laboratories  (BOM:532039) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Zenotech Laboratories's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=61.38/86.01
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zenotech Laboratories Median PS Value Related Terms

Thank you for viewing the detailed overview of Zenotech Laboratories's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Zenotech Laboratories (BOM:532039) Business Description

Traded in Other Exchanges
N/A
Address
Survey No. 250-252, Turkapally Village, Shamirpet Mandal, RR District, Hyderabad, TG, IND, 500 078
Zenotech Laboratories Ltd is an India-based pharmaceutical company. It is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. It also manufactures products such as granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The company earns a vast majority of the revenue from the sale of its contract research and manufacturing services.

Zenotech Laboratories (BOM:532039) Headlines

No Headlines